" /> PhenX - skin cancer protocol 170601:-:Pt: Patient:-:PhenX - CISMeF





Preferred Label : PhenX - skin cancer protocol 170601:-:Pt: Patient:-:PhenX;

LOINC status : TRIAL;

LOINC long common name : PhenX - skin cancer protocol 170601;

LOINC short name : Skin cancer proto;

LOINC description : The protocol developed by Quereux et al. (2010) includes a self administered questionnaire that captures the main skin cancer risk factors, such as skin type, presence of freckles and moles, occurrence of blistering sunburns and personal and family history of melanoma. After the respondent completes the questionnaire, the physician then examines the respondent regarding the number of nevi, freckling tendency, and phototype (hair and eye color, complexion and tanning ability). Then the physician checks the answers provided by the respondent and completes the questionnaire. Questions 1-3 of the questionnaire for self-assessment of melanoma risk factors have been deleted. These questions asked the respondent's age, gender, and occupation. The PhenX Skin, Bone, Muscle and Joint Working Group (WG) recommends that this information be obtained via the PhenX measures titled Current Age, Gender, and Current Employment Status, respectively. The Working Group recommends that as an alternative to a physician, a trained technician can conduct the physical examination.;

Details


You can consult :


Nous contacter.
28/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.